A Review of Therapies for <i>Clostridioides difficile</i> Infection
<i>Clostridioides difficile</i> is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of <i>Clostridioides difficile</i> infection (CDI), it remains a leading cause...
Saved in:
Main Authors: | Faiza Morado, Neha Nanda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/1/17 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
by: Roberto Rosato, et al.
Published: (2024-12-01) -
Metronidazole and Vancomycin Have a Synergic Effect, with Plant Extracts as Helpful Tools to Combat <i>Clostridioides difficile</i> Infections
by: Nancy C. Ruiz-Pérez, et al.
Published: (2025-01-01) -
Clinical Practice Guidelines of the Scientific Society for the Clinical Study of Human Microbiome, of the Russian Gastroenterological Association and the Russian Society for the Prevention of Noncommunicable Diseases on the Diagnosis and Treatment of <i>Clostridioides difficile</i> (<i>C. difficile</i>)-associated Disease in Adults
by: V. T. Ivashkin, et al.
Published: (2023-09-01) -
Modern Approaches to the Diagnosis and treatment of <i>Clostridioides difficile (C. difficile)</i>-associated Disease in Adults (literature Review and Expert Council Resolution)
by: V. T. Ivashkin, et al.
Published: (2023-08-01) -
Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against <i>Clostridioides difficile</i> Infection
by: Shaohui Wang, et al.
Published: (2024-12-01)